Os Therapies Incorporated · AMEX:OSTX
Thomas A. Satterfield, Jr. reported a 5.90% stake in Os Therapies Incorporated (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 12, 2025
Thomas A. Satterfield, Jr. reported a 5.90% stake in Os Therapies Incorporated, 1,267,465 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G/A).
- Stake
- 5.90%
- Shares
- 1,267,465
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Thomas A. Satterfield, Jr. | 5.90% | 1,267,465 |
Source
Related
- Os Therapies Incorporated
- Thomas A. Satterfield, Jr.
- Os Therapies Incorporated shareholders
- Schedule 13G/A · Thomas A. Satterfield, Jr. · Aug 13, 2025
- Schedule 13D/A · Shalom Auerbach · Aug 18, 2025
- Schedule 13D/A · Shalom Auerbach · May 9, 2025
- Schedule 13G · Ayala Pharmaceuticals, Inc. · Apr 16, 2025
- Schedule 13D/A · Shalom Auerbach · Mar 12, 2025
- Schedule 13D/A · Shalom Auerbach · Feb 28, 2025